Europe's insulin pump market was valued at USD 1.62 billion in 2025 and is expected to reach USD 3.5 billion by 2035, growing at a CAGR of 8%, driven by rising diabetes prevalence, technological advancements, and increasing adoption of advanced insulin delivery systems.

Europe Insulin Pump Market Statical Scope

The market is mainly influenced by the increasing number of diabetes cases, significant healthcare spending, and the swift adoption of advanced, Artificial Intelligence -powered, and connected smart insulin pump technologies.

This market is vital as the second-largest globally, fueled by the growing prevalence of Type 1 diabetes and substantial healthcare expenditures. It caters to an expanding patient population with cutting-edge, integrated smart technology, with Germany, France, and the U.K. being major contributors. There is a noticeable trend towards automated insulin delivery systems and hybrid closed-loop systems, enhancing glycemic control and patient comfort. The market is propelled by the need for smaller devices, patch pumps, and smart technologies that offer data connectivity and AI-driven insights.

Europe Insulin Pump Market Share, By Type, 2025 (%)

• Patch Pumps - Patch Pumps dominate the market with a 46% share, fueled by the growing preference among patients for discreet, wearable, and user-friendly insulin delivery options that enhance lifestyle convenience and adherence.
• Tethered Pumps - Tethered Pumps have a slightly higher share of 54%, backed by their proven clinical reliability, wider hospital acceptance, and their effectiveness for precise and adjustable insulin dosing in complex diabetes management scenarios.

Europe Insulin Pump Market Share, By Product, 2025 (%)

• MiniMed - MiniMed leads with a 24% market share, due to its strong brand presence, integration of advanced pump technology, and widespread clinical confidence in insulin management systems.
• Accu-Chek - Accu-Chek holds 14% of the market, supported by its affordability, robust distribution network, and ongoing use in both hospital and home diabetes management.

Europe Insulin Pump Market Share, By Accessories, 2025 (%)

• Insulin Reservoir/Cartridges - Insulin Reservoir/Cartridges lead the segment with a 45% share, driven by the ongoing need for replacements and their crucial role in the operation of continuous insulin pumps.
• Insulin Set Insertion Devices - Insulin Set Insertion Devices represent 35% of the market, valued for their role in ensuring accurate and hygienic setup for effective insulin delivery.

Europe Insulin Pump Market Share, By End Use, 2025 (%)

• Hospitals & Clinics - Hospitals & Clinics account for 38%, supported by their significant use in clinical monitoring, diabetes initiation therapy, and specialized patient care environments.
• Homecare - Homecare leads the segment with a 57% share, driven by the growing preference for self-managed diabetes care and the increasing adoption of wearable insulin pump technology for everyday use.

Top Companies in the Europe Insulin Pump Market

• Medtronic
• Hoffmann-La Roche AG
• Tandem Diabetes Care, Inc.
• Insulet Corporation
• Ypsomed
• Sanofi S.A.
• Sooil development
• Jiangsu Delfu Co., Ltd.
• Cellnovo Ltd
• Valeritas, Inc

Segments Covered in the Report

By Type

• Patch pumps
• Tethered pumps

By Product

• MiniMed
• Accu-Chek
• Tandem
• Omnipod
• My life omnipod
• Others

By Accessories

• Insulin reservoir or cartridges
• Insulin set insertion devices
• Battery

By End User

• Hospitals & clinics
• Homecare
• Laboratories